Combined treatment of prednisolone and angiotensin II receptor blocker in IgA nephropathy.

被引：0
|
作者：
Ihm, CG
Lee, SH
Lee, SH
Kim, YH
Lee, T
Kim, MJ
机构：
[1] Kyung Hee Univ, Coll Med, Seoul, South Korea
[2] InJe Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752A / 752A
页数：1
相关论文
共 50 条
  • [21] Efficacy of new combination therapy with prednisolone, mizoribine, and lisinopril for severe childhood IgA Nephropathy.
    Shima, Yuko
    Mukaiyama, Hironobu
    Tanaka, Yu
    Kaito, Hiroshi
    Tanaka, Ryojiro
    Nozu, Kandai
    Iijima, Kazumoto
    Tokuhara, Daisuke
    Yoshikawa, Norishige
    Nakanishi, Koichi
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2406 - 2407
  • [22] Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker
    Bakris, George L.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (01): : 27 - 32
  • [23] Angiotensin II type 1 receptor genotype and response to angiotensin II receptor blocker valsartan in early stage diabetic nephropathy
    Takei, Kako
    Kimura, Tomomi
    Miyazaki, Mitsuhiro
    Matsumoto, Ryuma
    muramatsu, Masaaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 223 - 223
  • [24] Renoprotective effects of adding an angiotensin II receptor blocker to maximal recommended doses of ACE-inhibitor in patients with Type 2 diabetes and nephropathy.
    Rossing, K
    Jacobsen, P
    Pietraszek, L
    Parving, HH
    DIABETOLOGIA, 2003, 46 : A338 - A339
  • [25] Effects of Combined Treatment with Angiotensin II Type 1 Receptor Blocker and Statin on Stent Restenosis
    Yoshikawa, Masaki
    Nakamura, Kazufumi
    Nagase, Satoshi
    Sakuragi, Satoru
    Kusano, Kengo F.
    Matsubara, Hiromi
    Ohe, Tohru
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (02) : 179 - U2
  • [26] Treatment of diabetic nephropathy with angiotensin II receptor antagonist
    E. J. Lewis
    J. B. Lewis
    Clinical and Experimental Nephrology, 2003, 7 (1) : 0001 - 0008
  • [27] Icatibant in the treatment of angiotensin II receptor blocker induced angioedema
    Strassen, U.
    Bas, M.
    Hoffmann, T.
    Greve, J.
    ALLERGY, 2012, 67 : 359 - 359
  • [28] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    DIABETOLOGIA, 1999, 42 : A10 - A10
  • [29] Combined treatment of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker in kidney transplant recipients with persistent proteinuria
    Tuncer, M
    Kocak, H
    Yavuz, A
    Karatas, GU
    Erdogan, O
    Gurkan, A
    Dinckan, A
    Ersoy, F
    Yakupoglu, G
    Demirbas, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V15 - V15
  • [30] Combining ACE inhibitors and angiotensin II receptor blockers to decrease proteinuria in patients with diabetic nephropathy.
    Dhillon, KK
    Mason, E
    Nanovic, L
    Laplace, L
    McCune, TR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 602A - 602A
12345